TLR1 (human, Q15399) review notes

Sources: UniProt Q15399, GOA (80 seeded rows; the GOA tsv has 81 lines, two IDA
GO:0035354 rows from PMID:16880211 collapse into one), cached publications, and
TLR1-deep-research-falcon.md (Falcon, completed during this review; consistent with
the primary literature below and used only as background).

Core biology

Key curation decisions

  1. GO:0001875 lipopolysaccharide immune receptor activity (IDA, contributes_to,
    PMID:16880211) -> MODIFY to GO:0038187 pattern recognition receptor activity.
    The definition requires combining with LPS; TLR1:TLR2 binds triacyl lipopeptide.
    The same term is used in GO-CAM 5fb9cc0600000727 (TLR1-TLR2 complex); flagged as a
    suggested question rather than edited.
  2. GO:0031663 LPS-mediated signaling pathway (IEA, GO_REF:0000108, inferred from the
    GO:0001875 row) -> REMOVE; it is an artefact of the mis-fitting MF term.
  3. protein binding rows: TLR2 partners -> MODIFY to GO:0035663 Toll-like receptor 2
    binding; TLR10 (co-IP, PMID:15728506) -> MODIFY to GO:0035325 Toll-like receptor
    binding; isolated-TMD (E. coli ToxR) partners TLR6/TLR10 and BioPlex TLR6 -> REMOVE.
  4. Cytokine-production regulation terms (IL-6, IL-8, TNF; ISS/IEA/IGI) and positive
    regulation of TLR2 signaling (IGI, PMID:22198949) -> KEEP_AS_NON_CORE (downstream
    outcomes / co-receptor role). Microglial cell activation (rat IEA) and macrophage
    activation (NAS citing an IFN-induction expression paper) -> MARK_AS_OVER_ANNOTATED.
  5. Core functions: contributes_to GO:0038187 in GO:0035354 at the plasma membrane,
    directly in GO:0038123 and GO:0042495; plus GO:0042497 triacyl lipopeptide binding
    (structure-based; recorded as a core function, not as a NEW annotation, since
    GO:0071723 lipopeptide binding is already accepted).

Relevance to project questions